2021
DOI: 10.1021/acsnano.1c00957
|View full text |Cite
|
Sign up to set email alerts
|

Thermoplasmonic-Assisted Cyclic Cleavage Amplification for Self-Validating Plasmonic Detection of SARS-CoV-2

Abstract: The coronavirus disease 2019 (COVID-19) has penetrated every populated patch of the globe and sows destruction in our daily life. Reliable and sensitive virus sensing systems are therefore of vital importance for timely infection detection and transmission prevention. Here we present a thermoplasmonic-assisted dual-mode transducing (TP-DMT) concept, where an amplification-free-based direct viral RNA detection and an amplification-based cyclic fluorescence probe cleavage (CFPC) detection collaborated to provide… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
72
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 50 publications
(73 citation statements)
references
References 49 publications
1
72
0
Order By: Relevance
“…However, the detection strategy involving the PPT effect of this biosensor is only suitable for the detection of nucleic acid, and not protein or enzyme, as the photothermal effect can literally denature the protein molecules [93]. This work further extends the utility of the photothermal-assisted plasmonic sensing biosensing system with the introduction of the thermoplasmonic-assisted dual-mode transducing (TP-DMT) concept [94]. The TP-DMT involves two types of approaches, which are an amplification-free-based direct viral RNA detection (direct sensing system) and an amplification-based cyclic fluorescence probe cleavage (CFPC) detection.…”
Section: Localized Surface Plasmon Resonancementioning
confidence: 91%
See 2 more Smart Citations
“…However, the detection strategy involving the PPT effect of this biosensor is only suitable for the detection of nucleic acid, and not protein or enzyme, as the photothermal effect can literally denature the protein molecules [93]. This work further extends the utility of the photothermal-assisted plasmonic sensing biosensing system with the introduction of the thermoplasmonic-assisted dual-mode transducing (TP-DMT) concept [94]. The TP-DMT involves two types of approaches, which are an amplification-free-based direct viral RNA detection (direct sensing system) and an amplification-based cyclic fluorescence probe cleavage (CFPC) detection.…”
Section: Localized Surface Plasmon Resonancementioning
confidence: 91%
“…This work further extends the utility of the photothermal-assisted plasmonic sensing biosensing system with the introduction of the thermoplasmonic-assisted dual-mode transducing (TP-DMT) concept [ 94 ]. The TP-DMT involves two types of approaches, which are an amplification-free-based direct viral RNA detection (direct sensing system) and an amplification-based cyclic fluorescence probe cleavage (CFPC) detection.…”
Section: The Development Of Optical and Electrochemical Metal Nanoparticles-based Biosensors For The Detection Of Viral Rnamentioning
confidence: 98%
See 1 more Smart Citation
“…Finally, the extracted biomacromolecules were analyzed for quantitative detection of bioaerosols [ 94 ]. A thermoplasmonic-assisted dual-mode transducer was presented to detect the SARS-CoV-2 viruses in 30 min, where an amplification-free-based direct viral RNA detection and an amplification-based cyclic fluorescence probe cleavage detection were combined and demonstrated as a potential tool for fast clinical infection screening and real-time environmental monitoring [ 95 ]. Besides, some other molecular biological detection methods were also applied to detect the SARS-CoV-2 viruses [ 96 , 97 ].…”
Section: Pathogen Detectionmentioning
confidence: 99%
“…Qiu et al [ 70 ] have reported the application of a nanoplatform including AuNI plasmonic chip for the quantitative measurement of SARS-CoV-2 within 30 min. They have suggested a novel concept based on the amplification-free-based direct viral RNA detection and an amplification-based cyclic fluorescence probe cleavage (CFPC) enabling the tests of clinical COVID-19 patient samples.…”
Section: Coronavirusesmentioning
confidence: 99%